Key result
Polymorphisms in the LPL, AGT, and GNB3 genes were significantly associated with ischemic cerebrovascular disease in a study of 928 cases and 602 controls.
Why the study?
Are specific genetic polymorphisms associated with ischemic cerebrovascular disease and carotid artery stenosis?
Case-Control (n=1,530)
Are specific genetic polymorphisms associated with ischemic cerebrovascular disease and carotid artery stenosis?
Specific genetic polymorphisms, particularly in the LPL, AGT, and GNB3 genes, are associated with ischemic cerebrovascular disease, and subtyping by carotid stenosis may identify additional candidate markers.
Does not support genetic testing for cerebrovascular risk; leaves open validation in prospective cohorts.
OBJECTIVES: Carotid artery stenosis (CS) is a major risk factor for ischemic cerebrovascular disease (ICVD) and is therefore of interest in genetic investigating. Here we report the distribution of 100 polymorphisms in 47 suspected susceptibility genes for ICVD and its risk factors. MATERIALS AND METHODS: Previously published markers in suspected susceptibility genes were genotyped in ICVD patients and controls (928/602). Genotyping was performed using multiplex polymerase chain reaction (PCR) and linear immobilized probe array assays. ICVD cases were subtyped according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) or subdivided into CS and non-CS patients by ultrasonography in a separate analysis. RESULTS: Three polymorphisms located in the lipoprotein lipase (LPL), angiotensinogen (AGT) and guanine nucleotide-binding protein beta-3 (GNB3) genes were significantly associated with ICVD after correction for age and gender. The strongest association was found for the protective LPL Ser447Term polymorphism. All the significant markers showed varying frequencies in different subphenotypes of ICVD. Factor VII, apolipoprotein E and two renin polymorphisms were differentially frequent in patients with evidence of CS compared with non-CS patients. CONCLUSIONS: We have found that some previously described susceptibility polymorphisms are weakly associated with ICVD and that subdivision of patients into CS and non-CS groups may help to identify new candidate polymorphisms.
No takes yet. Share an insight, caveat, or question.
Kostulas et al. (2008) conducted a case-control in Ischemic cerebrovascular disease and carotid stenosis (n=1,530). Polymorphisms in suspected susceptibility genes vs. Controls (absence of disease) was evaluated on Association with ischemic cerebrovascular disease. Polymorphisms in the LPL, AGT, and GNB3 genes were significantly associated with ischemic cerebrovascular disease in a study of 928 cases and 602 controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: